Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Go back to Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results
(NYSE: CLDI) Delayed: 0.95 -0.08 (7.77%)
Previous Close $1.03    52 Week High $ 
Open $1.00    52 Week Low $ 
Day High $1.00    P/E N/A 
Day Low $0.94    EPS $ 
Volume 53,575